Phillip Scheinberg is the New Editor-in-Chief of eJHaem
Dr. Phillip Scheinberg takes on the role of Editor-in-Chief for eJHaem, a leading journal in the field of hematology.
In this position, he brings his extensive expertise and leadership to guide the journal as it continues to publish high-quality research and clinical insights. Dr. Scheinberg is a recognized authority in hematology, specializing in blood disorders and hematologic malignancies. His clinical research background and contributions to advancing treatments make him well-suited to lead eJHaem into the future.
Dr. Phillip Scheinberg is a renowned hematologist with expertise in bone marrow failure syndromes and related hematological conditions. He currently serves as the Head of the Division of Hematology at Hospital A Beneficência Portuguesa in São Paulo, Brazil, where he leads clinical research, treatment initiatives, and patient care in hematology.
Dr. Scheinberg’s academic journey began at the University of Santo Amaro, São Paulo, Brazil, where he graduated in Medicine in 1995. He then pursued residencies in Internal Medicine at the University of São Paulo (1996–1997) and at Mount Sinai Medical Center in Florida, USA (1997–2000). His dedication to medical excellence continued with his appointment as Medical Chief Resident at Mount Sinai Medical Center from 2000 to 2001, where he honed his leadership and clinical skills.
Furthering his expertise in hematology, Dr. Scheinberg completed his fellowship and training at the Hematology Branch of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) from 2001 to 2006. During this period, he became deeply involved in clinical research and the development of protocols for treating bone marrow failure syndromes. His research focused on cellular immunity, bone marrow transplantation, and understanding immune responses against viral, tumoral, and allogeneic antigens. After completing his fellowship, Dr. Scheinberg continued his tenure at the NHLBI from 2006 to 2011, where he made significant contributions to laboratory research and clinical advancements in hematology.
In addition to his clinical and research work, Dr. Scheinberg has been widely recognized for his leadership in hematology and oncology. His expertise has led to the development of new treatment paradigms for bone marrow failure syndromes, which are often complex and difficult to treat. Dr. Scheinberg is also an Associate Editor for BJHaem (British Journal of Hematology), where he has helped shape the direction of scientific research and discussion in the field of hematology. His work continues to impact patient care worldwide, particularly in the areas of bone marrow disorders and hematologic malignancies.
About eJHaem Journal
eJHaem is a Gold Open Access journal published by Wiley and supported by the British Society for Haematology (BSH). Established to provide rapid dissemination of high-quality research in haematology, the journal covers key topics in blood disorders, including diagnosis, treatment, and management. With an emphasis on sound science, eJHaem publishes original research and reviews that are freely accessible to researchers worldwide.
The journal’s Gold Open Access model ensures that all articles are free to read and share, with authors retaining copyright. Indexed in major databases like PubMed and Web of Science, eJHaem offers wide visibility and impact. Known for its fast decision times, the journal has become a key resource for the global haematology community.
For more information, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023